New survey suggests many Black cancer patients aren't made aware of clinical trials
Clinical trials largely fail to enroll diverse patient populations — and in the last couple of years, patient advocates, the FDA and even a slate of pharma companies have taken steps to change that.
However, new research suggests that many Black patients aren’t made aware of trials in the first place.
Of 102 patients who self-identified as Black in a recent Metastatic Breast Cancer Alliance survey, 40% said that no one on their care team had discussed clinical trials. But more than 90% said they would be interested in learning about them, and 83% said they would be somewhat or very likely to consider participating.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.
